CB
The startup has developed a medical platform that administers therapeutics to the brain through the olfactory and trigeminal nerves. This approach aims to enhance the delivery of treatments for cerebral diseases, improving patient outcomes in neurology.
Updated 3 months ago
Funding
$6.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a medical platform that administers therapeutics to the brain through the olfactory and trigeminal nerves. This approach aims to enhance the delivery of treatments for cerebral diseases, improving patient outcomes in neurology.